tiprankstipranks
Trending News
More News >
Xilio Therapeutics (XLO)
NASDAQ:XLO
US Market
Advertisement

Xilio Therapeutics (XLO) Technical Analysis

Compare
189 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
5Neutral
11Bearish
Technical Analysis Consensus
Buy
3Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Xilio Therapeutics’s (XLO) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Xilio Therapeutics is a Buy.
Xilio Therapeutics’s (XLO) 20-Day exponential moving average is 0.71, while Xilio Therapeutics’s (XLO) share price is $0.7, making it a Sell.
Xilio Therapeutics’s (XLO) 50-Day exponential moving average is 0.73, while Xilio Therapeutics’s (XLO) share price is $0.7, making it a Sell.

Xilio Therapeutics (XLO) Pivot Points

Jul 26, 2025, 08:49 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.67
0.67
0.68
0.69
0.70
0.70
0.71
Fibonacci
0.67
0.68
0.68
0.69
0.69
0.70
0.70
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Xilio Therapeutics (XLO) Moving Averages

Jul 26, 2025, 08:49 PM
Period
Simple
Exponential
MA5
0.70Buy
0.70Buy
MA10
0.71Sell
0.70Sell
MA20
0.71Sell
0.71Sell
MA50
0.74Sell
0.73Sell
MA100
0.76Sell
0.77Sell
MA200
0.87Sell
0.83Sell
Xilio Therapeutics’s (XLO) 10-Day exponential moving average is 0.70, while Xilio Therapeutics’s (XLO) share price is $0.7, making it a Sell.
Xilio Therapeutics’s (XLO) 100-Day exponential moving average is 0.77, while Xilio Therapeutics’s (XLO) share price is $0.7, making it a Sell.
Xilio Therapeutics’s (XLO) stock price is $0.7 and Xilio Therapeutics’s (XLO) 50-day simple moving average is 0.74, creating a Sell signal.
Xilio Therapeutics’s (XLO) stock price is $0.7 and Xilio Therapeutics’s (XLO) 100-day simple moving average is 0.76, creating a Sell signal.
Xilio Therapeutics’s (XLO) stock price is $0.7 and Xilio Therapeutics’s (XLO) 200-day simple moving average is 0.87, creating a Sell signal.

Xilio Therapeutics (XLO) Technical Indicators

Jul 26, 2025, 08:49 PM
Name
Value
Implied Action
RSI (14)
46.96
Neutral
STOCH (9,6)
35.14
Neutral
STOCHRSI (14)
35.14
Neutral
MACD (12,26)
>-0.01
Buy
ADX (14)
14.60
Buy
Williams %R
-57.61
Buy
CCI (14)
-55.67
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
54.18
Neutral
ROC
0.00
Sell
Xilio Therapeutics’s (XLO) Relative Strength Index (RSI) is 46.96, creating a Neutral signal.
Xilio Therapeutics’s (XLO) Trend Strength Indicator (ADX) is 14.60, creating a Buy signal.
Xilio Therapeutics’s (XLO) Commodity Channel Index (CCI) is -55.67, creating a Neutral signal.

FAQ

Is XLO a Buy, Hold, or Sell?
Based on XLO’s technical indicators, XLO is a Sell.
    What is XLO’s RSI (14)?
    XLO’s RSI (14) is 46.96, which suggests XLO is a Neutral.
      What is XLO’s MACD?
      XLO’s MACD is >-0.01, which suggests XLO is a Buy.
        What is XLO’s 5-day moving average?
        XLO’s 5-day moving average is 0.70, which suggests XLO is a Buy.
          What is XLO’s 20-day moving average?
          XLO 20-day moving average is 0.71, which suggests XLO is a Sell.
            What is XLO’s 50-day moving average?
            XLO’s 50-day moving average is 0.74, which suggests XLO is a Sell.
              What is XLO’s 200-day moving average?
              XLO’s 200-day moving average is 0.87, which suggests XLO is a Sell.
                What is XLO’s Williams % R (14)?
                XLO’s Williams % R (14) is -57.61, which suggests XLO is a Buy.
                  What is XLO’s CCI (14)?
                  XLO’s CCI (14) is -55.67, which suggests XLO is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis